StockNews.com Begins Coverage on Alimera Sciences (NASDAQ:ALIM)

StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note published on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other equities analysts have also commented on ALIM. Maxim Group reaffirmed a hold rating on shares of Alimera Sciences in a report on Tuesday, […]

Leave a Reply

Your email address will not be published.

Previous post Financial Review: TRACON Pharmaceuticals (NASDAQ:TCON) & Tevogen Bio (NASDAQ:TVGN)
Next post Head-To-Head Analysis: Beachbody (NYSE:BODI) & American Battery Materials (OTCMKTS:BOXS)